483
Epitope Diagnostics, Inc.FDA 483 - Epitope Diagnostics, Inc. - April 28, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Epitope Diagnostics, Inc. in San Diego, CA, revealed two significant issues related to quality system procedures. The firm failed to develop written procedures for Medical Device Reports and inadequately established procedures for receiving, reviewing, and evaluating complaints. These observations indicate deficiencies in the firm's quality management system for medical device manufacturing.
Open in Dashboard
ID · 3580cf50-e508-4b21-af3d-a6c7abbc5a0f